RCM Technologies, Inc. Announces First-Quarter Results


PENNSAUKEN, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen weeks ended April 2, 2022.

RCM Technologies reported revenue of $82.0 million for the thirteen weeks ended April 2, 2022 (the current period), an 84.0% increase compared to $44.5 million for the thirteen weeks ended April 3, 2021 (the comparable prior-year period). Gross profit was $23.4 million for the current period, a 115.8% increase compared to $10.9 million for the comparable prior-year period.  The Company experienced GAAP operating income of $9.0 million for the current period compared to $1.4 million for the comparable prior-year period.  The Company experienced GAAP net income of $6.5 million, or $0.62 per diluted share, for the current period compared to $1.0 million, or $0.08 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA of $9.3 million for the current period compared to $1.8 million for the comparable prior-year period.

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “RCM’s first-quarter results demonstrated a good start to 2022. We continue to build on the strong foundation established and drive execution across our business units. We generated record profitability for the second-straight quarter, with adjusted EBITDA of $9.3 million, growing sequentially by 74% and 440% year-over-year. I want to thank the team for a job well done and their continued commitment to propelling RCM to the next level.”

Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “While growing revenue by over $17 million sequentially, we still generated approximately $2.5 million in cash flow from operations. We continue to benefit from the inherent leverage within our business model, and we expect to see strong cash flow generation throughout the balance of fiscal 2022.”

Conference Call
On Thursday, April 28, 2022, RCM Technologies will host a conference call to discuss these results. The call will begin at 10:00 a.m. Eastern Time. The dial-in number is (866) 403-9129.

About RCM
RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. RCM is an innovative leader in delivering these solutions to commercial and government sectors. RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America and Serbia. Additional information can be found at www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to the impact of the COVID-19 pandemic, demand for the Company’s services, expectations regarding our future revenues and other financial results, our pipeline, and potential project wins, and our expectations for growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

RCM Technologies, Inc.Tel: 856.356.4500Corporate Contacts:
2500 McClellan AvenueFax: 856.356.4600Bradley S. Vizi
Pennsauken, NJ 08109info@rcmt.com Executive Chairman
 www.rcmt.com Kevin D. Miller
  Chief Financial Officer

Tables to Follow

RCM Technologies, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(In Thousands, Except Per Share Amounts)

 Thirteen Weeks Ended
 April 2,
2022
 April 3,
2021
Revenue$81,961 $44,549
Cost of services 58,541  33,699
Gross profit 23,420  10,850
Selling, general and administrative 14,147  9,129
Depreciation and amortization of property and equipment 238  266
Amortization of acquired intangible assets -  80
Operating income 9,035  1,375
Other expense, net 52  12
Income before income taxes 8,983  1,363
Income tax expense 2,463  356
Net income$6,520 $1,007
    
Diluted net earnings per share data$0.62 $0.08

RCM Technologies, Inc.
Summary Consolidated Selected Balance Sheet Data
(In Thousands)

 April 2,
2022
 January 1,
2022
 (Unaudited)  
Cash and cash equivalents$859 $235
Accounts receivable, net$58,757 $48,240
Total current assets$63,069 $51,971
Total assets$84,210 $72,852
Total current liabilities$35,654 $29,857
Borrowings under line of credit$15,287 $14,151
Net debt (line of credit less cash)$14,428 $13,916
Total liabilities$54,008 $46,883
Stockholders’ equity$30,202 $25,969

RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis
(Unaudited)
(In Thousands)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“EBITDA” and “Adjusted EBITDA”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  EBITDA and Adjusted EBITDA should not be considered an alternative to net income as an indicator of performance.  In addition, EBITDA and Adjusted EBITDA do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company’s GAAP net income and the corresponding adjustments used to calculate EBITDA and Adjusted EBITDA for the thirteen weeks ended April 2, 2022, and April 3, 2021. 

 Thirteen Weeks Ended 
 April 2,
2022
  April 3,
2021
 
GAAP net income$6,520  $1,007 
Income tax expense 2,463   356 
Interest expense, net 97   121 
Change in fair value of contingent consideration -   26 
Depreciation of property and equipment 238   266 
Amortization of acquired intangible assets -   80 
EBITDA (non-GAAP)$9,318  $1,856 
       
Adjustments     
 Gain on foreign currency transactions (45)  (135)
Adjusted EBITDA (non-GAAP)$9,273  $1,781 

RCM Technologies, Inc.
Summary of Selected Income Statement Data
(Unaudited)
(In Thousands)

 Thirteen Weeks Ended April 2, 2022 
 Engineering  Specialty
Health Care
  Information
Technology
  

Consolidated
 
            
Revenue$19,898  $52,184  $9,879  $81,961 
Cost of services 14,664   37,183   6,694   58,541 
Gross profit$5,234  $15,001  $3,185  $23,420 
Gross profit margin 26.3%  28.7%  32.2%  28.6%


 Thirteen Weeks Ended April 3, 2021 
 Engineering  Specialty
Health Care
  Information
Technology
  

Consolidated
 
            
Revenue$14,466  $21,137  $8,946  $44,549 
Cost of services 11,260   16,099   6,340   33,699 
Gross profit$3,206  $5,038  $2,606  $10,850 
Gross profit margin 22.2%  23.8%  29.1%  24.4%

RCM Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In Thousands)

 Thirteen Weeks Ended 
 April 2,
2022
  April 3,
2021
 
Net income$6,520  $1,007 
Adjustments to reconcile net income to cash
provided by operating activities
 63   1,177 
Changes in operating assets and liabilities:     
 Accounts receivable (10,214)  (9,125)
 Prepaid expenses and other current assets 91   498 
 Net of transit accounts receivable and payable 521   (1,802)
 Accounts payable and accrued expenses (974)  47 
 Accrued payroll and related costs 5,440   17 
 Right of use liabilities 117   (511)
 Income taxes payable 1,824   (85)
 Deferred revenue (922)  (335)
 Deposits 2   - 
Total adjustments (4,052)  (10,119)
Net cash provided by (used in) operating activities 2,468   (9,112)
      
Net cash used in investing activities (217)  (47)
Net cash (used in) provided by financing activities (1,612)  9,215 
Effect of exchange rate changes (15)  (112)
Increase (decrease) in cash and cash equivalents$624   ($56)